Abstract
In the approximately 10-year period since the introduction of intra-operative parathyroid hormone testing, a variety of hormones have proven to be valuable tools in the surgical management of patients with various types of resectable tumors. To what extent the current list of hormones/markers performed intraoperatively will expand will be related, in part, to the speed with which new hormones/tumor markers are identified that meet the criteria indicated below for useful markers in point-of-surgery testing (POST). With the exception of intra-operative parathyroid hormone (ioPTH) testing, testing for the other hormones indicated below is performed at specialized centers using either modified commercial (“home-brew”) or research use only (RUO) assays.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
